Feedback / Questions
aleniglipron (GSBR-1290) - Structure Therap
https://www.globenewswire.com/news-release/2025/12/08/3201469/0/en/Structure-Therapeutics-Reports-Positive-Topline-Data-from-ACCESS-Program-for-its-Once-Daily-Oral-Small-Molecule-GLP-1-Receptor-Agonist-Aleniglipron.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next